Direkt zum Inhalt
Merck

Inactivation of AKT induces cellular senescence in uterine leiomyoma.

Endocrinology (2014-01-31)
Xiaofei Xu, Zhenxiao Lu, Wenan Qiang, Vania Vidimar, Beihua Kong, J Julie Kim, Jian-Jun Wei
ZUSAMMENFASSUNG

Uterine leiomyomas (fibroids) are a major public health problem. Current medical treatments with GnRH analogs do not provide long-term benefit. Thus, permanent shrinkage or inhibition of fibroid growth via medical means remains a challenge. The AKT pathway is a major growth and survival pathway for fibroids. We propose that AKT inhibition results in a transient regulation of specific mechanisms that ultimately drive cells into cellular senescence or cell death. In this study, we investigated specific mechanisms of AKT inhibition that resulted in senescence. We observed that administration of MK-2206, an allosteric AKT inhibitor, increased levels of reactive oxygen species, up-regulated the microRNA miR-182 and several senescence-associated genes (including p16, p53, p21, and β-galactosidase), and drove leiomyoma cells into stress-induced premature senescence (SIPS). Moreover, induction of SIPS was mediated by HMGA2, which colocalized to senescence-associated heterochromatin foci. This study provides a conceivable molecular mechanism of SIPS by AKT inhibition in fibroids.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
β-Galactosidase aus Aspergillus oryzae, ≥8.0 units/mg solid
Sigma-Aldrich
ββ-Galactosidase aus E. coli, Grade VIII, lyophilized powder, ≥500 units/mg protein
Sigma-Aldrich
ββ-Galactosidase aus E. coli, Grade VI, lyophilized powder, ≥250 units/mg protein
Sigma-Aldrich
ββ-Galactosidase aus E. coli, aqueous glycerol suspension, ≥500 units/mg protein (biuret)
Sigma-Aldrich
ββ-Galactosidase aus E. coli, lyophilized powder, ≥500 units/mg protein
Sigma-Aldrich
Dihydroethidium, BioReagent, suitable for fluorescence, ≥95% (HPCE)
Sigma-Aldrich
Dihydroethidium, ≥95%
Sigma-Aldrich
ββ-Galactosidase aus E. coli, suitable for enzyme immunoassay, lyophilized, powder, ~140 U/mg
Sigma-Aldrich
β-Galactosidase from bovine liver, Grade III, lyophilized powder, ≥0.15 units/mg protein
Sigma-Aldrich
β-Galactosidase from bovine testes, ammonium sulfate suspension, 1.0-3.0 units/mg protein (modified Warburg-Christian)